December 04, 2025

BMI Changes Linked to Adult CHD

Swedish cohort shows weight normalization before young adulthood is associated with coronary disease risk comparable to peers with lifelong normal weight.

Conexiant

December 01, 2025

WHO Issues Conditional GLP-1 Obesity Guideline

New recommendations emphasize equity barriers, health-system readiness, and the need for integrated chronic-disease management.

Conexiant

November 25, 2025

GLP-1 Drugs Cut Serious Infection Risk

Large meta-analysis shows weight loss and glycemic control drive protective effects across multiple organ systems

Conexiant

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 19, 2025

Diabetes Hearing Loss Link Confirmed

Meta-analysis reveals disease duration and blood sugar control as key factors in auditory decline

Conexiant

November 18, 2025

‘Designed to Scare People’? New Contraception Data

Hormonal contraception shows overall safety with a modest, short-term rise in breast cancer risk.

KFF Health News

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 14, 2025

The Risk Factor Going Unscreened

Adverse childhood experiences drive elevated all-cause mortality across medical conditions, with emergency department patients also showing nearly double the death rates.

Conexiant